| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 1.857 | 452.384 | 172.922 | 130.328 | 257.640 | 333.875 |
| Total Income - EUR | - | - | - | - | 2.201 | 461.759 | 174.246 | 130.922 | 258.830 | 337.868 |
| Total Expenses - EUR | - | - | - | - | 6.083 | 110.088 | 231.503 | 109.766 | 209.519 | 334.598 |
| Gross Profit/Loss - EUR | - | - | - | - | -3.882 | 351.670 | -57.257 | 21.156 | 49.311 | 3.270 |
| Net Profit/Loss - EUR | - | - | - | - | -3.940 | 346.877 | -58.696 | 19.852 | 46.941 | 694 |
| Employees | - | - | - | - | 0 | 0 | 3 | 2 | 1 | 3 |
Check the financial reports for the company - Vidos Medica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 9 | 21 | 9.140 | 6.384 | 15.415 | 11.800 |
| Current Assets | - | - | - | - | 4.089 | 444.575 | 319.859 | 317.705 | 385.601 | 334.770 |
| Inventories | - | - | - | - | 1.689 | 353.658 | 231.416 | 225.794 | 240.008 | 248.105 |
| Receivables | - | - | - | - | 0 | 80.618 | 73.333 | 71.306 | 107.962 | 74.357 |
| Cash | - | - | - | - | 2.400 | 10.300 | 15.110 | 20.604 | 37.631 | 12.308 |
| Shareholders Funds | - | - | - | - | -3.864 | 343.086 | 276.783 | 297.493 | 310.272 | -16.442 |
| Social Capital | - | - | - | - | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | - | - | 7.962 | 101.510 | 52.258 | 26.639 | 91.285 | 363.433 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Vidos Medica S.r.l.